Publicacions en què col·labora amb Javier Muriel Serrano (12)

2024

  1. clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach

    Minerva Anestesiologica, Vol. 90, Núm. 5, pp. 386-396

2023

  1. Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

    Acta Pharmaceutica, Vol. 73, Núm. 2, pp. 227-241

2022

  1. Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

    Scientific Reports, Vol. 12, Núm. 1

  2. Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study

    Biomedicines, Vol. 10, Núm. 9

2020

  1. Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain

    Clinical Journal of Pain, Vol. 36, Núm. 6, pp. 420-429

2019

  1. Efectividad y farmacogenética en un protocolo de desprescripción en pacientes con dolor crónico y dependencia iatrogénica a opioides

    IV Jornadas Doctorales Escuela Internacional de Doctorado de la Universidad de Murcia (Eidum)

  2. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability

    Journal of Psychopharmacology, Vol. 33, Núm. 11, pp. 1395-1406

  3. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study

    Pain Practice, Vol. 19, Núm. 8, pp. 836-847

  4. Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients

    Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 4, pp. 439-448

2018

  1. Efectividad y farmacogenética en un protocolo de desprescripción en pacientes con dolor crónico y dependencia iatrogénica a opioides

    Anales de la Real Academia Nacional de Farmacia, Vol. 84, Núm. 2, pp. 204-213

  2. Effectiveness and pharmacogenetics in a deprescription protocol in chronic pain patients and iatrogenic opioid dependence

    Anales de la Real Academia Nacional de Farmacia, Vol. 84, Núm. 2, pp. 204-213

  3. OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients

    Annals of the New York Academy of Sciences, Vol. 1425, Núm. 1, pp. 82-93